Tevogen (TVGN) Operating Leases (2023 - 2026)
Tevogen's (TVGN) quarterly Operating Leases came in at $1.1 million in Q1 2026, down 2.56% quarter-over-quarter from $1.1 million in Q4 2025.
Analysis
Tevogen (TVGN) Operating Leases (2023 - 2026) Analysis & Trends
Tevogen (TVGN) has reported Operating Leases for 4 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $1.1 million, up 19271.12% from the prior year.
- Operating Leases retreated to $1.1 million in Q1 2026 per TVGN's latest filing, from $1.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $1.2 million in Q2 2025 and bottomed at $5796.0 in Q4 2024.
- Historically, Operating Leases has averaged $565688.4 across 4 years, with a median of $234858.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Operating Leases sank 97.53% in 2024, then surged 19271.12% in 2025.
- Over 4 years, Operating Leases stood at $234858.0 in 2023, then tumbled by 97.53% to $5796.0 in 2024, then soared by 19271.12% to $1.1 million in 2025, then fell by 2.56% to $1.1 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $1.1 million, $1.1 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Tevogen | 27.76 Mn | 27.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Dec 31, 2024 | 5,796.00 |
| Sep 30, 2024 | 42,567.00 |
| Jun 30, 2024 | 96,809.00 |
| Mar 31, 2024 | 166,788.00 |
| Dec 31, 2023 | 234,858.00 |